Harpoon Therapeutics Inc. (HARP) NASDAQ
$23.01 0.02 (0.09%)
Market Cap: -
As of 03/08/24 04:00 PM EST. Market closed.
Harpoon Therapeutics Inc. (HARP)
NASDAQ
$23.01
0.02 (0.09%)
Market Cap: -
As of 03/08/24 04:00 PM EST. Market closed.
Add to Portfolio
harpoon therapeutics is a pre-clinical stage biotechnology company co-founded by patrick bauerle, a pioneer in t-cell engagement, and luke evnin (mpm capital) in 2015 to develop and commercialize a novel class of t cell recruiting antibodies engage a patient’s own immune cells to fight cancer and other diseases. the world-class team of protein engineers and immunologists at harpoon have built ... read more
COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
Gerald McMahon
Address
131 Oyster Point Blvd Ste 300, California, South San Francisco, 94080-1910.
PRICE CHART FOR HARPOON THERAPEUTICS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$22.99
Days Range
$22.99 - $23.02
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
16,932,272
Open
-
Previous Close
$22.99
Days Range
$22.99 - $23.02
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
16,932,272
FINANCIAL STATEMENTS FOR HARPOON THERAPEUTICS INC
LOADING...
INSIDER TRANSACTIONS FOR HARPOON THERAPEUTICS INC
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Merck & Co., Inc. | 10% Owner | Mar 11, 2024 | Buy | $23.00 | 21,397,205 | 492,135,715 | 1,000 | Mar 11, 2024, 03:27 PM |
HUNT RONALD | Director | Mar 23, 2023 | Buy | $1000.00 | 10,000 | 10,000,000 | 10,000 | Mar 27, 2023, 05:37 PM |
Erbez Georgia | Chief Financial Officer | Sep 22, 2021 | Buy | $8.10 | 10,300 | 83,430 | 19,215 | Sep 22, 2021, 09:30 PM |
New Leaf Ventures III, L.P. | 10% Owner | Jan 11, 2021 | Buy | $17.00 | 235,294 | 3,999,998 | 913,860 | Aug 12, 2021, 04:15 PM |
HUNT RONALD | Director | Jan 11, 2021 | Buy | $17.00 | 235,294 | 3,999,998 | 913,860 | Aug 12, 2021, 04:15 PM |
Wesche Holger | Chief Scientific Officer | Jul 01, 2021 | Option Exercise | $0.60 | 10,000 | 6,000 | 62,852 | Jul 06, 2021, 06:01 PM |
Wesche Holger | Chief Scientific Officer | Jul 01, 2021 | Sale | $14.00 | 10,000 | 140,000 | 52,852 | Jul 06, 2021, 06:01 PM |
GADICKE ANSBERT | 10% Owner | Jun 02, 2021 | Sale | $20.50 | 25,118 | 514,919 | 6,328,095 | Jun 02, 2021, 06:09 PM |
GADICKE ANSBERT | 10% Owner | Jun 01, 2021 | Sale | $20.44 | 18,491 | 377,956 | 6,353,213 | Jun 02, 2021, 06:09 PM |
GADICKE ANSBERT | 10% Owner | May 28, 2021 | Sale | $21.12 | 13,885 | 293,315 | 6,374,904 | Jun 02, 2021, 06:09 PM |
GADICKE ANSBERT | 10% Owner | May 27, 2021 | Sale | $20.26 | 13,961 | 282,850 | 6,385,589 | May 27, 2021, 07:40 PM |
GADICKE ANSBERT | 10% Owner | May 26, 2021 | Sale | $20.04 | 3,198 | 64,088 | 6,399,550 | May 27, 2021, 07:40 PM |
GADICKE ANSBERT | 10% Owner | May 24, 2021 | Sale | $20.12 | 5,000 | 100,600 | 6,402,748 | May 24, 2021, 08:11 PM |
GADICKE ANSBERT | 10% Owner | May 21, 2021 | Sale | $20.21 | 10,907 | 220,430 | 6,407,748 | May 24, 2021, 08:11 PM |
GADICKE ANSBERT | 10% Owner | May 18, 2021 | Sale | $20.67 | 18,402 | 380,369 | 6,448,201 | May 20, 2021, 07:20 PM |
GADICKE ANSBERT | 10% Owner | May 20, 2021 | Sale | $20.34 | 11,713 | 238,242 | 6,418,655 | May 20, 2021, 07:20 PM |
GADICKE ANSBERT | 10% Owner | May 19, 2021 | Sale | $20.39 | 17,833 | 363,615 | 6,430,368 | May 20, 2021, 07:20 PM |
GADICKE ANSBERT | 10% Owner | May 17, 2021 | Sale | $20.07 | 4,666 | 93,647 | 6,466,603 | May 17, 2021, 05:23 PM |
GADICKE ANSBERT | 10% Owner | May 14, 2021 | Sale | $20.04 | 6,900 | 138,276 | 6,471,269 | May 17, 2021, 05:23 PM |
GADICKE ANSBERT | 10% Owner | May 13, 2021 | Sale | $20.06 | 4,855 | 97,391 | 6,478,169 | May 17, 2021, 05:23 PM |
GADICKE ANSBERT | 10% Owner | May 05, 2021 | Sale | $22.52 | 10,172 | 229,107 | 6,551,345 | May 06, 2021, 04:05 PM |
GADICKE ANSBERT | 10% Owner | Apr 21, 2021 | Sale | $18.97 | 8,972 | 170,229 | 7,020,675 | Apr 22, 2021, 04:04 PM |
GADICKE ANSBERT | 10% Owner | Apr 16, 2021 | Sale | $19.86 | 5,847 | 116,110 | 7,061,697 | Apr 20, 2021, 06:07 PM |
GADICKE ANSBERT | 10% Owner | Apr 20, 2021 | Sale | $18.71 | 22,249 | 416,382 | 7,029,926 | Apr 20, 2021, 06:07 PM |
GADICKE ANSBERT | 10% Owner | Apr 19, 2021 | Sale | $19.30 | 10,056 | 194,059 | 7,051,441 | Apr 20, 2021, 06:07 PM |
MPM BioVentures 2014, L.P. | Former 10% Owner | Apr 13, 2021 | Sale | $19.46 | 1,943 | 37,806 | 3,223,853 | Apr 15, 2021, 08:01 PM |
MPM BioVentures 2014, L.P. | Former 10% Owner | Apr 15, 2021 | Sale | $20.49 | 1,052 | 21,555 | 3,220,844 | Apr 15, 2021, 08:01 PM |
MPM BioVentures 2014, L.P. | Former 10% Owner | Apr 14, 2021 | Sale | $20.77 | 1,671 | 34,714 | 3,223,446 | Apr 15, 2021, 08:01 PM |
GADICKE ANSBERT | 10% Owner | Apr 15, 2021 | Sale | $20.49 | 8,696 | 178,181 | 7,067,244 | Apr 15, 2021, 08:00 PM |
GADICKE ANSBERT | 10% Owner | Apr 14, 2021 | Sale | $20.77 | 13,806 | 286,809 | 7,088,746 | Apr 15, 2021, 08:00 PM |
GADICKE ANSBERT | 10% Owner | Apr 13, 2021 | Sale | $19.46 | 16,054 | 312,369 | 7,092,108 | Apr 15, 2021, 08:00 PM |
MPM BioVentures 2014, L.P. | 10% Owner | Apr 12, 2021 | Sale | $21.02 | 2,496 | 52,460 | 3,226,369 | Apr 13, 2021, 04:12 PM |
MPM BioVentures 2014, L.P. | 10% Owner | Apr 09, 2021 | Sale | $23.67 | 10,300 | 243,801 | 3,228,006 | Apr 13, 2021, 04:12 PM |
Wesche Holger | Chief Scientific Officer | Apr 01, 2021 | Option Exercise | $0.60 | 10,000 | 6,000 | 62,852 | Apr 05, 2021, 05:00 PM |
Wesche Holger | Chief Scientific Officer | Apr 01, 2021 | Sale | $20.45 | 10,000 | 204,491 | 53,352 | Apr 05, 2021, 05:00 PM |
Erbez Georgia | Chief Financial Officer | Feb 17, 2021 | Option Exercise | $2.12 | 25,000 | 53,000 | 72,292 | Feb 18, 2021, 08:31 AM |
MPM BioVentures 2014, L.P. | 10% Owner | Feb 10, 2021 | Sale | $20.00 | 183,051 | 3,661,020 | 3,238,306 | Feb 12, 2021, 05:03 PM |
MPM BioVentures 2014, L.P. | 10% Owner | Feb 10, 2021 | Sale | $20.00 | 183,051 | 3,661,020 | 3,238,306 | Feb 12, 2021, 05:03 PM |
MPM BioVentures 2014, L.P. | 10% Owner | Feb 09, 2021 | Sale | $20.25 | 9,400 | 190,350 | 3,421,357 | Feb 09, 2021, 06:14 PM |
MPM BioVentures 2014, L.P. | 10% Owner | Feb 08, 2021 | Sale | $20.04 | 72,128 | 1,445,445 | 3,430,757 | Feb 09, 2021, 06:14 PM |
MPM BioVentures 2014, L.P. | 10% Owner | Feb 05, 2021 | Sale | $20.01 | 10,172 | 203,542 | 3,502,885 | Feb 09, 2021, 06:14 PM |
MPM BioVentures 2014, L.P. | 10% Owner | Feb 02, 2021 | Sale | $20.13 | 48,421 | 974,715 | 3,584,709 | Feb 04, 2021, 07:30 PM |
MPM BioVentures 2014, L.P. | 10% Owner | Feb 04, 2021 | Sale | $20.37 | 29,730 | 605,600 | 3,513,057 | Feb 04, 2021, 07:30 PM |
MPM BioVentures 2014, L.P. | 10% Owner | Feb 03, 2021 | Sale | $20.21 | 41,922 | 847,244 | 3,542,787 | Feb 04, 2021, 07:30 PM |
MPM BioVentures 2014, L.P. | 10% Owner | Jan 27, 2021 | Sale | $20.00 | 706,825 | 14,136,500 | 3,633,130 | Jan 27, 2021, 08:35 PM |
MPM BioVentures 2014, L.P. | 10% Owner | Jan 26, 2021 | Sale | $21.08 | 1,363 | 28,732 | 4,339,955 | Jan 27, 2021, 08:35 PM |
MPM BioVentures 2014, L.P. | 10% Owner | Jan 25, 2021 | Sale | $21.23 | 13,006 | 276,117 | 4,341,318 | Jan 27, 2021, 08:35 PM |
MPM BioVentures 2014, L.P. | 10% Owner | Jan 20, 2021 | Sale | $24.04 | 17,694 | 425,291 | 4,508,731 | Jan 22, 2021, 08:16 PM |
MPM BioVentures 2014, L.P. | 10% Owner | Jan 22, 2021 | Sale | $21.72 | 24,695 | 536,375 | 4,354,324 | Jan 22, 2021, 08:16 PM |
MPM BioVentures 2014, L.P. | 10% Owner | Jan 21, 2021 | Sale | $22.22 | 26,066 | 579,095 | 4,384,106 | Jan 22, 2021, 08:16 PM |
Wesche Holger | Chief Scientific Officer | Jan 04, 2021 | Option Exercise | $0.60 | 10,000 | 6,000 | 62,852 | Jan 06, 2021, 06:25 PM |
Wesche Holger | Chief Scientific Officer | Jan 04, 2021 | Sale | $18.38 | 10,000 | 183,837 | 59,752 | Jan 06, 2021, 06:25 PM |
Wesche Holger | Chief Scientific Officer | Oct 01, 2020 | Option Exercise | $0.60 | 10,000 | 6,000 | 62,669 | Oct 05, 2020, 04:25 PM |
Wesche Holger | Chief Scientific Officer | Oct 01, 2020 | Sale | $16.27 | 10,000 | 162,737 | 53,669 | Oct 05, 2020, 04:25 PM |
Erbez Georgia | Chief Financial Officer | Aug 19, 2020 | Buy | $11.40 | 5,000 | 57,000 | 8,915 | Aug 20, 2020, 06:36 PM |
Erbez Georgia | Chief Financial Officer | Aug 18, 2020 | Buy | $11.60 | 2,098 | 24,337 | 3,915 | Aug 20, 2020, 06:36 PM |
Erbez Georgia | Chief Financial Officer | Jul 31, 2020 | Buy | $10.92 | 1,817 | 19,842 | 1,817 | Aug 04, 2020, 08:32 AM |
Wesche Holger | Chief Scientific Officer | Jul 01, 2020 | Option Exercise | $0.60 | 10,000 | 6,000 | 62,669 | Jul 02, 2020, 07:18 PM |
Wesche Holger | Chief Scientific Officer | Jul 01, 2020 | Sale | $16.20 | 10,000 | 161,989 | 52,669 | Jul 02, 2020, 07:18 PM |
Arix Bioscience plc | 10% Owner | May 28, 2020 | Sale | $21.33 | 366,591 | 7,820,926 | 2,193,704 | May 29, 2020, 04:32 PM |
Arix Bioscience plc | 10% Owner | May 27, 2020 | Sale | $22.39 | 12,064 | 270,144 | 2,560,295 | May 29, 2020, 04:32 PM |
Sacks Natalie | Chief Medical Officer | May 18, 2020 | Option Exercise | $2.12 | 1,522 | 3,227 | 47,276 | May 20, 2020, 06:34 PM |
Sacks Natalie | Chief Medical Officer | May 18, 2020 | Sale | $14.77 | 1,522 | 22,479 | 45,754 | May 20, 2020, 06:34 PM |
Wesche Holger | Chief Scientific Officer | May 12, 2020 | Option Exercise | $0.60 | 1,400 | 840 | 54,069 | May 13, 2020, 08:45 PM |
Wesche Holger | Chief Scientific Officer | May 12, 2020 | Sale | $14.09 | 1,400 | 19,720 | 52,669 | May 13, 2020, 08:45 PM |
Wesche Holger | Chief Scientific Officer | May 08, 2020 | Option Exercise | $0.60 | 1,000 | 600 | 53,669 | May 11, 2020, 09:37 PM |
Wesche Holger | Chief Scientific Officer | May 07, 2020 | Option Exercise | $0.60 | 5,350 | 3,210 | 58,019 | May 11, 2020, 09:37 PM |
Wesche Holger | Chief Scientific Officer | May 11, 2020 | Option Exercise | $0.60 | 1,000 | 600 | 53,669 | May 11, 2020, 09:37 PM |
Wesche Holger | Chief Scientific Officer | May 07, 2020 | Sale | $14.13 | 5,350 | 75,576 | 52,669 | May 11, 2020, 09:37 PM |
Wesche Holger | Chief Scientific Officer | May 11, 2020 | Sale | $14.07 | 1,000 | 14,065 | 52,669 | May 11, 2020, 09:37 PM |
Wesche Holger | Chief Scientific Officer | May 08, 2020 | Sale | $14.00 | 1,000 | 14,000 | 52,669 | May 11, 2020, 09:37 PM |
Sacks Natalie | Chief Medical Officer | May 01, 2020 | Option Exercise | $2.12 | 5,826 | 12,351 | 51,580 | May 05, 2020, 04:35 PM |
Sacks Natalie | Chief Medical Officer | May 01, 2020 | Sale | $12.07 | 5,826 | 70,301 | 45,754 | May 05, 2020, 04:35 PM |
Wesche Holger | Chief Scientific Officer | Apr 28, 2020 | Option Exercise | $0.60 | 1,250 | 750 | 53,919 | Apr 30, 2020, 04:58 PM |
Wesche Holger | Chief Scientific Officer | Apr 28, 2020 | Sale | $14.05 | 1,250 | 17,565 | 52,669 | Apr 30, 2020, 04:58 PM |
Sacks Natalie | Chief Medical Officer | Apr 17, 2020 | Option Exercise | $2.12 | 1,021 | 2,165 | 46,775 | Apr 17, 2020, 07:10 PM |
Sacks Natalie | Chief Medical Officer | Apr 16, 2020 | Option Exercise | $2.12 | 500 | 1,060 | 46,254 | Apr 17, 2020, 07:10 PM |
Sacks Natalie | Chief Medical Officer | Apr 17, 2020 | Sale | $12.08 | 1,021 | 12,330 | 45,754 | Apr 17, 2020, 07:10 PM |
Sacks Natalie | Chief Medical Officer | Apr 16, 2020 | Sale | $12.00 | 500 | 6,000 | 45,754 | Apr 17, 2020, 07:10 PM |
Sacks Natalie | Chief Medical Officer | Apr 13, 2020 | Option Exercise | $2.12 | 4,556 | 9,659 | 50,310 | Apr 15, 2020, 04:48 PM |
Sacks Natalie | Chief Medical Officer | Apr 13, 2020 | Sale | $12.06 | 4,556 | 54,959 | 45,754 | Apr 15, 2020, 04:48 PM |
Sacks Natalie | Chief Medical Officer | Apr 07, 2020 | Option Exercise | $2.12 | 570 | 1,208 | 46,324 | Apr 08, 2020, 06:10 PM |
Sacks Natalie | Chief Medical Officer | Apr 06, 2020 | Option Exercise | $2.12 | 700 | 1,484 | 46,454 | Apr 08, 2020, 06:10 PM |
Sacks Natalie | Chief Medical Officer | Apr 07, 2020 | Sale | $12.00 | 570 | 6,840 | 45,754 | Apr 08, 2020, 06:10 PM |
Sacks Natalie | Chief Medical Officer | Apr 06, 2020 | Sale | $12.00 | 700 | 8,401 | 45,754 | Apr 08, 2020, 06:10 PM |
Sacks Natalie | Chief Medical Officer | Mar 16, 2020 | Option Exercise | $2.12 | 1 | 2 | 45,755 | Mar 18, 2020, 05:28 PM |
Sacks Natalie | Chief Medical Officer | Mar 17, 2020 | Option Exercise | $2.12 | 1,520 | 3,222 | 47,274 | Mar 18, 2020, 05:28 PM |
Sacks Natalie | Chief Medical Officer | Mar 17, 2020 | Sale | $12.00 | 1,520 | 18,240 | 45,754 | Mar 18, 2020, 05:28 PM |
Sacks Natalie | Chief Medical Officer | Mar 16, 2020 | Sale | $12.00 | 1 | 12 | 45,754 | Mar 18, 2020, 05:28 PM |
Sacks Natalie | Chief Medical Officer | Mar 02, 2020 | Option Exercise | $2.12 | 5,826 | 12,351 | 51,580 | Mar 03, 2020, 09:31 PM |
Sacks Natalie | Chief Medical Officer | Mar 02, 2020 | Sale | $14.68 | 5,826 | 85,526 | 45,754 | Mar 03, 2020, 09:31 PM |
Sacks Natalie | Chief Medical Officer | Feb 18, 2020 | Option Exercise | $2.12 | 1,521 | 3,225 | 47,275 | Feb 20, 2020, 05:11 PM |
Sacks Natalie | Chief Medical Officer | Feb 18, 2020 | Sale | $15.00 | 1,521 | 22,815 | 45,754 | Feb 20, 2020, 05:11 PM |
Sacks Natalie | Chief Medical Officer | Feb 03, 2020 | Option Exercise | $2.12 | 5,826 | 12,351 | 51,580 | Feb 04, 2020, 08:11 PM |
Sacks Natalie | Chief Medical Officer | Feb 03, 2020 | Sale | $13.90 | 5,826 | 81,006 | 45,754 | Feb 04, 2020, 08:11 PM |
Erbez Georgia | Chief Financial Officer | Jan 21, 2020 | Buy | $14.09 | 6,700 | 94,418 | 6,700 | Jan 23, 2020, 08:34 AM |
Sacks Natalie | Chief Medical Officer | Jan 16, 2020 | Option Exercise | $2.12 | 1,521 | 3,225 | 47,275 | Jan 21, 2020, 08:05 PM |
Sacks Natalie | Chief Medical Officer | Jan 16, 2020 | Sale | $14.94 | 1,521 | 22,725 | 45,754 | Jan 21, 2020, 08:05 PM |
Wesche Holger | Chief Scientific Officer | Jan 02, 2020 | Option Exercise | $0.60 | 10,000 | 6,000 | 62,669 | Jan 06, 2020, 09:55 PM |
Wesche Holger | Chief Scientific Officer | Jan 02, 2020 | Sale | $14.40 | 10,000 | 143,987 | 52,669 | Jan 06, 2020, 09:55 PM |
Sacks Natalie | Chief Medical Officer | Jan 02, 2020 | Option Exercise | $2.12 | 5,826 | 12,351 | 51,580 | Jan 06, 2020, 09:46 PM |
Sacks Natalie | Chief Medical Officer | Jan 02, 2020 | Sale | $14.18 | 5,826 | 82,600 | 45,754 | Jan 06, 2020, 09:46 PM |
Baeuerle Patrick | Director | Dec 27, 2019 | Sale | $15.98 | 87,379 | 1,396,281 | 273,953 | Dec 30, 2019, 05:32 PM |
Sacks Natalie | Chief Medical Officer | Dec 16, 2019 | Option Exercise | $2.12 | 1,521 | 3,225 | 47,275 | Dec 18, 2019, 04:14 PM |
Sacks Natalie | Chief Medical Officer | Dec 16, 2019 | Sale | $17.02 | 1,521 | 25,888 | 45,754 | Dec 18, 2019, 04:14 PM |
Chin Mark | Director | Dec 13, 2019 | Sale | $17.21 | 11,002 | 189,341 | 2,597,915 | Dec 17, 2019, 09:23 PM |
Chin Mark | Director | Dec 17, 2019 | Sale | $16.83 | 12,476 | 209,969 | 2,572,359 | Dec 17, 2019, 09:23 PM |
Chin Mark | Director | Dec 16, 2019 | Sale | $17.02 | 13,080 | 222,680 | 2,584,835 | Dec 17, 2019, 09:23 PM |
Arix Bioscience plc | 10% Owner | Dec 17, 2019 | Sale | $16.83 | 12,476 | 209,969 | 2,572,359 | Dec 17, 2019, 07:20 PM |
Arix Bioscience plc | 10% Owner | Dec 16, 2019 | Sale | $17.02 | 13,080 | 222,680 | 2,584,835 | Dec 17, 2019, 07:20 PM |
Arix Bioscience plc | 10% Owner | Dec 13, 2019 | Sale | $17.21 | 11,002 | 189,341 | 2,597,915 | Dec 17, 2019, 07:20 PM |
Chin Mark | Director | Dec 10, 2019 | Sale | $16.91 | 131,696 | 2,227,019 | 2,608,917 | Dec 10, 2019, 08:07 PM |
Chin Mark | Director | Dec 09, 2019 | Sale | $18.16 | 103,754 | 1,884,445 | 2,817,929 | Dec 10, 2019, 08:07 PM |
Chin Mark | Director | Dec 06, 2019 | Sale | $19.15 | 47,752 | 914,222 | 2,844,367 | Dec 10, 2019, 08:07 PM |
Arix Bioscience plc | 10% Owner | Dec 10, 2019 | Sale | $16.91 | 131,696 | 2,227,019 | 2,608,917 | Dec 10, 2019, 07:27 PM |
Arix Bioscience plc | 10% Owner | Dec 09, 2019 | Sale | $18.16 | 103,754 | 1,884,445 | 2,817,929 | Dec 10, 2019, 07:27 PM |
Arix Bioscience plc | 10% Owner | Dec 06, 2019 | Sale | $19.15 | 47,752 | 914,222 | 2,844,367 | Dec 10, 2019, 07:27 PM |
Erbez Georgia | Chief Financial Officer | Dec 04, 2019 | Option Exercise | $2.12 | 47,292 | 100,259 | 47,292 | Dec 06, 2019, 04:41 PM |
Sacks Natalie | Chief Medical Officer | Dec 02, 2019 | Option Exercise | $2.12 | 5,826 | 12,351 | 51,580 | Dec 04, 2019, 04:42 PM |
Sacks Natalie | Chief Medical Officer | Dec 02, 2019 | Sale | $17.98 | 5,826 | 104,751 | 45,754 | Dec 04, 2019, 04:42 PM |
Sacks Natalie | Chief Medical Officer | Nov 18, 2019 | Option Exercise | $2.12 | 18,252 | 38,694 | 64,006 | Nov 19, 2019, 04:24 PM |
Sacks Natalie | Chief Medical Officer | Nov 18, 2019 | Sale | $13.37 | 18,252 | 243,964 | 46,754 | Nov 19, 2019, 04:24 PM |
Sacks Natalie | Chief Medical Officer | Nov 01, 2019 | Option Exercise | $2.12 | 5,826 | 12,351 | 51,580 | Nov 05, 2019, 04:09 PM |
Sacks Natalie | Chief Medical Officer | Nov 01, 2019 | Sale | $13.17 | 5,826 | 76,702 | 45,754 | Nov 05, 2019, 04:09 PM |
Sacks Natalie | Chief Medical Officer | Oct 14, 2019 | Option Exercise | $2.12 | 12,452 | 26,398 | 58,206 | Oct 16, 2019, 05:14 PM |
Sacks Natalie | Chief Medical Officer | Oct 15, 2019 | Option Exercise | $2.12 | 11,698 | 24,800 | 57,452 | Oct 16, 2019, 05:14 PM |
Sacks Natalie | Chief Medical Officer | Oct 14, 2019 | Sale | $13.27 | 12,452 | 165,280 | 45,754 | Oct 16, 2019, 05:14 PM |
Sacks Natalie | Chief Medical Officer | Oct 15, 2019 | Sale | $13.21 | 11,698 | 154,481 | 45,754 | Oct 16, 2019, 05:14 PM |
McMahon Gerald PhD | President and CEO | Jun 05, 2019 | Option Exercise | $0.60 | 169,462 | 101,677 | 172,462 | Sep 06, 2019, 07:17 PM |
McMahon Gerald PhD | President and CEO | May 14, 2019 | Buy | $10.16 | 1,000 | 10,157 | 3,000 | May 16, 2019, 08:32 AM |
McMahon Gerald PhD | President and CEO | May 08, 2019 | Buy | $10.56 | 1,000 | 10,559 | 2,000 | May 10, 2019, 08:31 AM |
McMahon Gerald PhD | President and CEO | May 03, 2019 | Buy | $10.53 | 1,000 | 10,530 | 1,000 | May 07, 2019, 04:12 PM |
Arix Bioscience plc | 10% Owner | Feb 12, 2019 | Buy | $14.00 | 428,571 | 5,999,994 | 2,892,119 | Feb 14, 2019, 06:01 PM |
UBS Oncology Impact Fund L.P. | 10% Owner | Feb 12, 2019 | Buy | $14.00 | 250,000 | 3,500,000 | 3,898,422 | Feb 14, 2019, 05:34 PM |
UBS Oncology Impact Fund L.P. | 10% Owner | Feb 12, 2019 | Sale | $14.00 | 447 | 6,258 | 3,648,422 | Feb 14, 2019, 05:34 PM |
UBS Oncology Impact Fund L.P. | 10% Owner | Feb 12, 2019 | Option Exercise | $0.05 | 127,096 | 6,253 | 3,648,869 | Feb 14, 2019, 05:34 PM |
New Leaf Ventures III, L.P. | 10% Owner | Feb 12, 2019 | Buy | $14.00 | 428,571 | 5,999,994 | 2,242,839 | Feb 14, 2019, 05:33 PM |
MPM BioVentures 2014, L.P. | 10% Owner | Feb 12, 2019 | Buy | $14.00 | 250,000 | 3,500,000 | 4,524,425 | Feb 14, 2019, 05:32 PM |
MPM BioVentures 2014, L.P. | 10% Owner | Feb 12, 2019 | Sale | $14.00 | 1,524 | 21,336 | 4,274,425 | Feb 14, 2019, 05:32 PM |
MPM BioVentures 2014, L.P. | 10% Owner | Feb 12, 2019 | Option Exercise | $0.05 | 432,119 | 21,260 | 4,275,949 | Feb 14, 2019, 05:32 PM |
HUNT RONALD | Director | Feb 12, 2019 | Buy | $14.00 | 428,571 | 5,999,994 | 2,242,839 | Feb 14, 2019, 05:30 PM |
GADICKE ANSBERT | 10% Owner | Feb 12, 2019 | Buy | $14.00 | 500,000 | 7,000,000 | 8,422,847 | Feb 14, 2019, 05:28 PM |
GADICKE ANSBERT | 10% Owner | Feb 12, 2019 | Sale | $14.00 | 1,971 | 27,594 | 7,922,847 | Feb 14, 2019, 05:28 PM |
GADICKE ANSBERT | 10% Owner | Feb 12, 2019 | Option Exercise | $0.05 | 559,215 | 27,513 | 7,924,818 | Feb 14, 2019, 05:28 PM |
Chin Mark | Director | Feb 12, 2019 | Buy | $14.00 | 428,571 | 5,999,994 | 2,892,119 | Feb 14, 2019, 05:24 PM |
EVNIN LUKE | Director | Feb 12, 2019 | Option Exercise | $14.00 | 1,524 | 21,336 | 4,274,425 | Feb 14, 2019, 05:19 PM |
EVNIN LUKE | Director | Feb 12, 2019 | Buy | $14.00 | 250,000 | 3,500,000 | 4,524,425 | Feb 14, 2019, 05:19 PM |
EVNIN LUKE | Director | Feb 12, 2019 | Option Exercise | $0.05 | 432,119 | 21,260 | 4,275,949 | Feb 14, 2019, 05:19 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
Merck & Co., Inc. | 10% Owner | 03/11/2024 | 492,135,715 |
HUNT RONALD | Director | 03/23/2023 | 10,000,000 |
Erbez Georgia | Chief Financial Officer | 09/22/2021 | 83,430 |
New Leaf Ventures III, L.P. | 10% Owner | 01/11/2021 | 3,999,998 |
HUNT RONALD | Director | 01/11/2021 | 3,999,998 |
Wesche Holger | Chief Scientific Officer | 07/01/2021 | 6,000 |
Wesche Holger | Chief Scientific Officer | 07/01/2021 | 140,000 |
GADICKE ANSBERT | 10% Owner | 06/02/2021 | 514,919 |
GADICKE ANSBERT | 10% Owner | 06/01/2021 | 377,956 |
GADICKE ANSBERT | 10% Owner | 05/28/2021 | 293,315 |
GADICKE ANSBERT | 10% Owner | 05/27/2021 | 282,850 |
GADICKE ANSBERT | 10% Owner | 05/26/2021 | 64,088 |
GADICKE ANSBERT | 10% Owner | 05/24/2021 | 100,600 |
GADICKE ANSBERT | 10% Owner | 05/21/2021 | 220,430 |
GADICKE ANSBERT | 10% Owner | 05/18/2021 | 380,369 |
GADICKE ANSBERT | 10% Owner | 05/20/2021 | 238,242 |
GADICKE ANSBERT | 10% Owner | 05/19/2021 | 363,615 |
GADICKE ANSBERT | 10% Owner | 05/17/2021 | 93,647 |
GADICKE ANSBERT | 10% Owner | 05/14/2021 | 138,276 |
GADICKE ANSBERT | 10% Owner | 05/13/2021 | 97,391 |
GADICKE ANSBERT | 10% Owner | 05/05/2021 | 229,107 |
GADICKE ANSBERT | 10% Owner | 04/21/2021 | 170,229 |
GADICKE ANSBERT | 10% Owner | 04/16/2021 | 116,110 |
GADICKE ANSBERT | 10% Owner | 04/20/2021 | 416,382 |
GADICKE ANSBERT | 10% Owner | 04/19/2021 | 194,059 |
MPM BioVentures 2014, L.P. | Former 10% Owner | 04/13/2021 | 37,806 |
MPM BioVentures 2014, L.P. | Former 10% Owner | 04/15/2021 | 21,555 |
MPM BioVentures 2014, L.P. | Former 10% Owner | 04/14/2021 | 34,714 |
GADICKE ANSBERT | 10% Owner | 04/15/2021 | 178,181 |
GADICKE ANSBERT | 10% Owner | 04/14/2021 | 286,809 |
GADICKE ANSBERT | 10% Owner | 04/13/2021 | 312,369 |
MPM BioVentures 2014, L.P. | 10% Owner | 04/12/2021 | 52,460 |
MPM BioVentures 2014, L.P. | 10% Owner | 04/09/2021 | 243,801 |
Wesche Holger | Chief Scientific Officer | 04/01/2021 | 6,000 |
Wesche Holger | Chief Scientific Officer | 04/01/2021 | 204,491 |
Erbez Georgia | Chief Financial Officer | 02/17/2021 | 53,000 |
MPM BioVentures 2014, L.P. | 10% Owner | 02/10/2021 | 3,661,020 |
MPM BioVentures 2014, L.P. | 10% Owner | 02/10/2021 | 3,661,020 |
MPM BioVentures 2014, L.P. | 10% Owner | 02/09/2021 | 190,350 |
MPM BioVentures 2014, L.P. | 10% Owner | 02/08/2021 | 1,445,445 |
MPM BioVentures 2014, L.P. | 10% Owner | 02/05/2021 | 203,542 |
MPM BioVentures 2014, L.P. | 10% Owner | 02/02/2021 | 974,715 |
MPM BioVentures 2014, L.P. | 10% Owner | 02/04/2021 | 605,600 |
MPM BioVentures 2014, L.P. | 10% Owner | 02/03/2021 | 847,244 |
MPM BioVentures 2014, L.P. | 10% Owner | 01/27/2021 | 14,136,500 |
MPM BioVentures 2014, L.P. | 10% Owner | 01/26/2021 | 28,732 |
MPM BioVentures 2014, L.P. | 10% Owner | 01/25/2021 | 276,117 |
MPM BioVentures 2014, L.P. | 10% Owner | 01/20/2021 | 425,291 |
MPM BioVentures 2014, L.P. | 10% Owner | 01/22/2021 | 536,375 |
MPM BioVentures 2014, L.P. | 10% Owner | 01/21/2021 | 579,095 |
Wesche Holger | Chief Scientific Officer | 01/04/2021 | 6,000 |
Wesche Holger | Chief Scientific Officer | 01/04/2021 | 183,837 |
Wesche Holger | Chief Scientific Officer | 10/01/2020 | 6,000 |
Wesche Holger | Chief Scientific Officer | 10/01/2020 | 162,737 |
Erbez Georgia | Chief Financial Officer | 08/19/2020 | 57,000 |
Erbez Georgia | Chief Financial Officer | 08/18/2020 | 24,337 |
Erbez Georgia | Chief Financial Officer | 07/31/2020 | 19,842 |
Wesche Holger | Chief Scientific Officer | 07/01/2020 | 6,000 |
Wesche Holger | Chief Scientific Officer | 07/01/2020 | 161,989 |
Arix Bioscience plc | 10% Owner | 05/28/2020 | 7,820,926 |
Arix Bioscience plc | 10% Owner | 05/27/2020 | 270,144 |
Sacks Natalie | Chief Medical Officer | 05/18/2020 | 3,227 |
Sacks Natalie | Chief Medical Officer | 05/18/2020 | 22,479 |
Wesche Holger | Chief Scientific Officer | 05/12/2020 | 840 |
Wesche Holger | Chief Scientific Officer | 05/12/2020 | 19,720 |
Wesche Holger | Chief Scientific Officer | 05/08/2020 | 600 |
Wesche Holger | Chief Scientific Officer | 05/07/2020 | 3,210 |
Wesche Holger | Chief Scientific Officer | 05/11/2020 | 600 |
Wesche Holger | Chief Scientific Officer | 05/07/2020 | 75,576 |
Wesche Holger | Chief Scientific Officer | 05/11/2020 | 14,065 |
Wesche Holger | Chief Scientific Officer | 05/08/2020 | 14,000 |
Sacks Natalie | Chief Medical Officer | 05/01/2020 | 12,351 |
Sacks Natalie | Chief Medical Officer | 05/01/2020 | 70,301 |
Wesche Holger | Chief Scientific Officer | 04/28/2020 | 750 |
Wesche Holger | Chief Scientific Officer | 04/28/2020 | 17,565 |
Sacks Natalie | Chief Medical Officer | 04/17/2020 | 2,165 |
Sacks Natalie | Chief Medical Officer | 04/16/2020 | 1,060 |
Sacks Natalie | Chief Medical Officer | 04/17/2020 | 12,330 |
Sacks Natalie | Chief Medical Officer | 04/16/2020 | 6,000 |
Sacks Natalie | Chief Medical Officer | 04/13/2020 | 9,659 |
Sacks Natalie | Chief Medical Officer | 04/13/2020 | 54,959 |
Sacks Natalie | Chief Medical Officer | 04/07/2020 | 1,208 |
Sacks Natalie | Chief Medical Officer | 04/06/2020 | 1,484 |
Sacks Natalie | Chief Medical Officer | 04/07/2020 | 6,840 |
Sacks Natalie | Chief Medical Officer | 04/06/2020 | 8,401 |
Sacks Natalie | Chief Medical Officer | 03/16/2020 | 2 |
Sacks Natalie | Chief Medical Officer | 03/17/2020 | 3,222 |
Sacks Natalie | Chief Medical Officer | 03/17/2020 | 18,240 |
Sacks Natalie | Chief Medical Officer | 03/16/2020 | 12 |
Sacks Natalie | Chief Medical Officer | 03/02/2020 | 12,351 |
Sacks Natalie | Chief Medical Officer | 03/02/2020 | 85,526 |
Sacks Natalie | Chief Medical Officer | 02/18/2020 | 3,225 |
Sacks Natalie | Chief Medical Officer | 02/18/2020 | 22,815 |
Sacks Natalie | Chief Medical Officer | 02/03/2020 | 12,351 |
Sacks Natalie | Chief Medical Officer | 02/03/2020 | 81,006 |
Erbez Georgia | Chief Financial Officer | 01/21/2020 | 94,418 |
Sacks Natalie | Chief Medical Officer | 01/16/2020 | 3,225 |
Sacks Natalie | Chief Medical Officer | 01/16/2020 | 22,725 |
Wesche Holger | Chief Scientific Officer | 01/02/2020 | 6,000 |
Wesche Holger | Chief Scientific Officer | 01/02/2020 | 143,987 |
Sacks Natalie | Chief Medical Officer | 01/02/2020 | 12,351 |
Sacks Natalie | Chief Medical Officer | 01/02/2020 | 82,600 |
Baeuerle Patrick | Director | 12/27/2019 | 1,396,281 |
Sacks Natalie | Chief Medical Officer | 12/16/2019 | 3,225 |
Sacks Natalie | Chief Medical Officer | 12/16/2019 | 25,888 |
Chin Mark | Director | 12/13/2019 | 189,341 |
Chin Mark | Director | 12/17/2019 | 209,969 |
Chin Mark | Director | 12/16/2019 | 222,680 |
Arix Bioscience plc | 10% Owner | 12/17/2019 | 209,969 |
Arix Bioscience plc | 10% Owner | 12/16/2019 | 222,680 |
Arix Bioscience plc | 10% Owner | 12/13/2019 | 189,341 |
Chin Mark | Director | 12/10/2019 | 2,227,019 |
Chin Mark | Director | 12/09/2019 | 1,884,445 |
Chin Mark | Director | 12/06/2019 | 914,222 |
Arix Bioscience plc | 10% Owner | 12/10/2019 | 2,227,019 |
Arix Bioscience plc | 10% Owner | 12/09/2019 | 1,884,445 |
Arix Bioscience plc | 10% Owner | 12/06/2019 | 914,222 |
Erbez Georgia | Chief Financial Officer | 12/04/2019 | 100,259 |
Sacks Natalie | Chief Medical Officer | 12/02/2019 | 12,351 |
Sacks Natalie | Chief Medical Officer | 12/02/2019 | 104,751 |
Sacks Natalie | Chief Medical Officer | 11/18/2019 | 38,694 |
Sacks Natalie | Chief Medical Officer | 11/18/2019 | 243,964 |
Sacks Natalie | Chief Medical Officer | 11/01/2019 | 12,351 |
Sacks Natalie | Chief Medical Officer | 11/01/2019 | 76,702 |
Sacks Natalie | Chief Medical Officer | 10/14/2019 | 26,398 |
Sacks Natalie | Chief Medical Officer | 10/15/2019 | 24,800 |
Sacks Natalie | Chief Medical Officer | 10/14/2019 | 165,280 |
Sacks Natalie | Chief Medical Officer | 10/15/2019 | 154,481 |
McMahon Gerald PhD | President and CEO | 06/05/2019 | 101,677 |
McMahon Gerald PhD | President and CEO | 05/14/2019 | 10,157 |
McMahon Gerald PhD | President and CEO | 05/08/2019 | 10,559 |
McMahon Gerald PhD | President and CEO | 05/03/2019 | 10,530 |
Arix Bioscience plc | 10% Owner | 02/12/2019 | 5,999,994 |
UBS Oncology Impact Fund L.P. | 10% Owner | 02/12/2019 | 3,500,000 |
UBS Oncology Impact Fund L.P. | 10% Owner | 02/12/2019 | 6,258 |
UBS Oncology Impact Fund L.P. | 10% Owner | 02/12/2019 | 6,253 |
New Leaf Ventures III, L.P. | 10% Owner | 02/12/2019 | 5,999,994 |
MPM BioVentures 2014, L.P. | 10% Owner | 02/12/2019 | 3,500,000 |
MPM BioVentures 2014, L.P. | 10% Owner | 02/12/2019 | 21,336 |
MPM BioVentures 2014, L.P. | 10% Owner | 02/12/2019 | 21,260 |
HUNT RONALD | Director | 02/12/2019 | 5,999,994 |
GADICKE ANSBERT | 10% Owner | 02/12/2019 | 7,000,000 |
GADICKE ANSBERT | 10% Owner | 02/12/2019 | 27,594 |
GADICKE ANSBERT | 10% Owner | 02/12/2019 | 27,513 |
Chin Mark | Director | 02/12/2019 | 5,999,994 |
EVNIN LUKE | Director | 02/12/2019 | 21,336 |
EVNIN LUKE | Director | 02/12/2019 | 3,500,000 |
EVNIN LUKE | Director | 02/12/2019 | 21,260 |
Load More Insider Transactions
FUNDS WITH A POSITION IN HARPOON THERAPEUTICS INC
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
RA CAPITAL MANAGEMENT, L.P. | 1,500,000 | 0.27% | New | Other |
BLACKSTONE INC. | 815,000 | 0.04% | New | Other |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 300,000 | 0.00706% | New | Other |
BLACKROCK INC. | 249,834 | 0.00007% | 576.34% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 149,262 | 0.00018% | 499.13% | Other |
RENAISSANCE TECHNOLOGIES LLC | 12,756 | 0.00022% | -48.68% | Other |
CHANGE IN SHARES OUTSTANDING FOR HARPOON THERAPEUTICS INC
STOCK BUYBACKS FOR HARPOON THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 09/30/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
06/30/2023
3.97%
1Q
03/31/2023
6.79%
2Q
12/31/2022
17.19%
3Q
09/30/2022
19.41%
4Q
06/30/2022
19.50%
5Q
03/31/2022
20.08%
6Q
12/31/2021
21.22%
7Q
09/30/2021
20.96%
8Q
06/30/2021
21.46%
9Q
03/31/2021
25.02%
10Q
12/31/2020
55.06%
11Q
09/30/2020
57.41%
12Q
06/30/2020
58.17%
13Q
03/31/2020
59.03%
14Q
12/31/2019
68.88%
15Q
09/30/2019
61.42%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR HARPOON THERAPEUTICS INC
LOADING...